Piracetam and Ginkgo biloba in the treatment of residual cognitive symptoms after the discontinuation of benzodiazepines in long-term users; case series and review of the literature
Introduction Long-term benzodiazepine use is common although not routinely recommended. While their dependence potential is notorious, cognitive problems due to their chronic use have only recently been intensively studied. Residual cognitive symptoms may linger months after successful benzodiazepi...
Main Authors: | T. Sugnet, S. Jonovska, V. Šendula-Jengić, P. Čargonja |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823014001/type/journal_article |
Similar Items
-
Prevalence of comorbid pathological gambling in substance use disorders
by: P. Cargonja, et al.
Published: (2023-03-01) -
Effectiveness and Safety of Ginkgo biloba, Vinpocetine and Piracetam as a Single Agent and Fixed Dose Combination in Patients with Subjective Tinnitus
by: Paul Mathai, et al.
Published: (2021-02-01) -
Ginkgo Biloba
by: Sami J. Natour, MD, et al.
Published: (2020-06-01) -
Ginkgo biloba for the treatment of tinnitus
by: Felipe Kramer, et al.
Published: (2018-10-01) -
The anomalies of seeds of Ginkgo biloba L.
by: L.V. Sinitsyna
Published: (2000-03-01)